Topiramate treatment of pediatric metabolic dysfunction-associated steatotic liver disease: A descriptive cohort study
Activity Instructions: Read the full article and take the exam by clicking the "CE Information" tab.
CE Credit: CE credit available for dietitians, nurses, pharmacists and physicians
Total Credit Hours: 1.0
Release Date: April 1, 2025
Expiration Date (all CE credit must be claimed by the expiration date): March 31, 2026
Issue: 3
Volume: 49
Journal: Journal of Parenteral and Enteral Nutrition (JPEN)
Author (s):
Taisa Kohut, MD, Assistant Professor, Pediatric Gastroenterology, Hepatology and Nutrition, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, FL
Andrea Tou, MD, Fellow, Pediatric Gastroenterology, Children’s Hospital of Philadelphia, Philadelphia, PA
Emily Carr, MD, MPH, Practice Manager, Connecticut OCD, Anxiety, and Tic Specialists; Research Coordinator, Department of Pediatric Gastroenterology and Liver Transplant, Yale University School of Medicine, New Haven, CT
Stavra Xanthakos, MD, MS, Professor of Pediatrics, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Ana Catalina Arce-Clachar, MD, Associate Professor of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Rima Fawaz, MD, Associate Professor, Department of Pediatrics, Section of Gastroenterology and Hepatology, Yale School of Medicine, New Haven, CT
Pamela L. Valentino, MD, MSc, Associate Professor of Pediatrics, Department of Pediatrics, University of Washington, Seattle, WA
Jennifer Panganiban, MD, Associate Professor of Clinical Pediatrics (Gastroenterology, Hepatology, and Nutrition), University of Pennsylvania School of Medicine, Philadelphia, PA
Marialena Mouzaki, MD, MSc, Staff Physician, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Link to article: https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/jpen.2722
Journal-based CE Activity Overall Goal:
The JPEN Editor, in concurrence with ASPEN’s Education and Professional Development Committee, selected this article to be offered for CE credit to fill an observed learning need in the arena of clinical nutrition and metabolism. This CE activity serves to promote the process of life-long learning for physicians, dietitians, pharmacists, and nurses by providing peer-reviewed journal articles that fully qualify for continuing education credits.
Goal and Target Audience:
This educational activity is directed toward clinical nutrition and metabolism professionals and others who wish to update their knowledge of clinical nutrition and metabolism. By participating in this educational activity, the reader may expect to:
- Acquire knowledge in the area of clinical nutrition and metabolism research.
- Update or confirm your understanding of appropriate clinical nutrition and metabolism practices.
- Identify further learning needs as they relate to the subject matter.
Learning Objectives:
- Explain how topiramate can serve as an adjunct to lifestyle modification for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease (MASLD)
- Describe the potential effects of topiramate on anthropometrics and liver enzymes
- Identify which sub-group of patients with pediatric MASLD may most benefit from topiramate use
- Summarize safety considerations and monitor for potential side effects from topiramate
- Describe standard dosing and upwards titration of topiramate in this clinical context
Requirements for Successful Completion:
To obtain CE credit for this activity, attendees must read the journal article in its entirety, complete an online assessment for each article and achieve a score of 100%, and complete an online activity evaluation. All are located in ASPEN’s eLearning Center (www.nutritioncare.org/elearning). All CE credit must be claimed prior to the expiration date, no exceptions.
ASPEN submits data as required to the CPE Monitor for pharmacists. ASPEN submits physician earned CME credit into Pars. ASPEN does not submit data to any other credentialing organization.
Pharmacists and physicians, please note that ASPEN will upload earned CE credit into the appropriate system within the required timeframe. Any credit not claimed by the deadline will not be entered. Please provide your correct information when completing your evaluation and claiming CE credit. ASPEN submits only the information that is entered by the pharmacist or physician when credit is claimed and is not responsible for following up to obtain any corrected information to ensure an error-free submission.
Speakers
Related Products
